A person with neuroblastoma, which occurs when developing nerve cells in children turn cancerous, has remained tumour-free for over 18 years thanks to CAR T-cell therapy

CAR-T-cell therapy treated a girl with a rare childhood cancer, raising hopes for future recipients of the approach.

The woman, who had neuroblastoma as a child, had two healthy pregnancies since undergoing the trial, which uses modified white blood cells to attack cancer cells

A patient has achieved over 18 years of remission from neuroblastoma, a type of nerve cell cancer, following treatment with chimeric antigen receptor (CAR) T cell therapy and without requiring any additional treatments.

A groundbreaking study in Nature Medicine reveals that GD2 CAR-T cell therapy can lead to long-term remission in children with neuroblastoma, with one patient remaining cancer-free for over 18 years.